Drug intelligence / Profile preview

Hemagglutinin antigens

Development stage
Unknown
Lead developer
CSL Seqirus
Modality
Recombinant Proteins and Enzymes
Administration
Intramuscular, Intranasal
01

Overview

Hemagglutinin (HA) antigens are antigenic glycoproteins found on the surface of influenza viruses. They are responsible for binding the virus to host cells by attaching to sialic acid receptors on the cell surface, initiating the infection process. HA is a homotrimeric integral membrane glycoprotein with a dual function as both an attachment factor and membrane fusion protein. It is the primary target of protective antibody responses induced by viral infection and vaccination. HA antigens are a major component in influenza vaccines, including inactivated and live-attenuated formulations. The effectiveness of HA-based vaccines depends on the structural integrity of the antigens, with different serotypes (H1, H3, etc.) having different expression requirements for optimal protective antibody responses.

Other names
Influenza hemagglutinin antigens
02

Targets

Sialoglycan (Cell-surface sialoglycan)

Beyond the preview

Go deeper on Hemagglutinin antigens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemagglutinin antigens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call